Paris, France — 17 November 2025 — Genèse Labs has launched Exo-Mask, a post-treatment sheet mask formulated with rose stem-cell exosomes and salmon DNA (PDRN), extending its portfolio from treatment through to aftercare.

• Formulated with rose stem-cell exosomes, 1% salmon DNA (PDRN), NAD⁺, glutathione and hyaluronic acid

• Bio-cellular sheet with micro-bubble technology for an immediate cooling sensation

• Designed to soothe and comfort skin immediately after laser, RF and microneedling treatments

Modern procedures such as laser, RF and microneedling stimulate skin renewal effectively, but post-treatment redness, dryness and downtime affect patient satisfaction and treatment frequency. Where conventional sheet masks focus on comfort alone, Exo-Mask is designed to support the recovery process itself.

The bio-cellular sheet adheres closely to freshly treated skin, delivering ingredients evenly and creating an immediate cooling sensation through micro-bubble activation to ease post-treatment discomfort.

Procedure → apply Exo-Mask immediately → leave on for 15–20 minutes → recommend continued home use between sessions

Genèse Labs is a Paris-founded aesthetic company dedicated to science-based, regulatory-led product development across body contouring, collagen biostimulation, hyaluronic acid fillers and regenerative skincare. Since its foundation in 2019, the company has built its portfolio — including the RG Body Filler line, Proluma™ (PDLLA, PLLA and RH Collagen), Réluma, Citrus Bottle™, Exoluma™ (Human, Plant and Exo-PDRN) and Exo-Mask — on three principles: scientifically verifiable formulations, regulatory compliance in every market entered, and continuous engagement with the international clinical and academic community. Genèse Labs partners with dermatologists, aesthetic physicians and distributors worldwide to advance the standard of modern aesthetic medicine. For more information: www.geneselabs.net.